{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:11:34Z","timestamp":1780402294913,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T00:00:00Z","timestamp":1183334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1475-2875-6-86","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T06:15:16Z","timestamp":1183443316000},"source":"Crossref","is-referenced-by-count":16,"title":["Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals"],"prefix":"10.1186","volume":"6","author":[{"given":"Damon P","family":"Eisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Jouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Elsa H","family":"Murhandarwati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casilda G","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Mercereau-Puijalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L","family":"Coppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,2]]},"reference":[{"key":"391_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0166-6851(93)90002-F","volume":"59","author":"LH Miller","year":"1993","unstructured":"Miller LH, Roberts T, Shahabuddin M, McCutchan TF: Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol. 1993, 59: 1-14. 10.1016\/0166-6851(93)90002-F.","journal-title":"Mol Biochem Parasitol"},{"key":"391_CR2","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.193.12.1403","volume":"193","author":"RA O'Donnell","year":"2001","unstructured":"O'Donnell RA, de Koning-Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman AF, Crabb BS: Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med. 2001, 193: 1403-1412. 10.1084\/jem.193.12.1403.","journal-title":"J Exp Med"},{"key":"391_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1473-3099(02)00451-6","volume":"2","author":"SA Moore","year":"2002","unstructured":"Moore SA, Surgey EG, Cadwgan AM: Malaria vaccines: where are we and where are we going?. Lancet Infect Dis. 2002, 2: 737-743. 10.1016\/S1473-3099(02)00451-6.","journal-title":"Lancet Infect Dis"},{"key":"391_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/76272","volume":"6","author":"DJ Conway","year":"2000","unstructured":"Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, Bojang KA, Oduola AM, Kremsner PG, Arnot DE, Greenwood BM, McBride JS: A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med. 2000, 6: 689-692. 10.1038\/76272.","journal-title":"Nat Med"},{"key":"391_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/339342","volume":"185","author":"B Genton","year":"2002","unstructured":"Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP: A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis. 2002, 185: 820-827. 10.1086\/339342.","journal-title":"J Infect Dis"},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/IAI.67.5.2193-2200.1999","volume":"67","author":"L Wang","year":"1999","unstructured":"Wang L, Black CG, Marshall VM, Coppel RL: Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect Immun. 1999, 67: 2193-2200.","journal-title":"Infect Immun"},{"key":"391_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(98)00045-0","volume":"94","author":"VM Marshall","year":"1998","unstructured":"Marshall VM, Tieqiao W, Coppel RL: Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum. Mol Biochem Parasitol. 1998, 94: 13-25. 10.1016\/S0166-6851(98)00045-0.","journal-title":"Mol Biochem Parasitol"},{"key":"391_CR8","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1128\/IAI.72.10.5840-5849.2004","volume":"72","author":"MW Goschnick","year":"2004","unstructured":"Goschnick MW, Black CG, Kedzierski L, Holder AA, Coppel RL: Merozoite surface protein 4\/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect Immun. 2004, 72: 5840-5849. 10.1128\/IAI.72.10.5840-5849.2004.","journal-title":"Infect Immun"},{"key":"391_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-3024.2003.00647.x","volume":"25","author":"L Wang","year":"2003","unstructured":"Wang L, Crouch L, Richie TL, Nhan DH, Coppel RL: Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex. Parasite Immunol. 2003, 25: 403-412. 10.1111\/j.1365-3024.2003.00647.x.","journal-title":"Parasite Immunol"},{"key":"391_CR10","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1128\/IAI.72.6.3325-3330.2004","volume":"72","author":"AE Topolska","year":"2004","unstructured":"Topolska AE, Richie TL, Nhan DH, Coppel RL: Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection. Infect Immun. 2004, 72: 3325-3330. 10.1128\/IAI.72.6.3325-3330.2004.","journal-title":"Infect Immun"},{"key":"391_CR11","doi-asserted-by":"publisher","first-page":"81S","DOI":"10.1111\/j.1537-2995.2005.00540.x","volume":"45","author":"CP Nixon","year":"2005","unstructured":"Nixon CP, Friedman JF, Knopf PM, Duffy PE, Kurtis JD: Protective human immunity as a vaccine discovery tool for falciparum malaria. Transfusion. 2005, 45: 81S-87S. 10.1111\/j.1537-2995.2005.00540.x.","journal-title":"Transfusion"},{"key":"391_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4269\/ajtmh.2002.67.8","volume":"67","author":"DP Eisen","year":"2002","unstructured":"Eisen DP, Saul A, Fryauff DJ, Reeder JC, Coppel RL: Alterations in Plasmodium falciparum genotypes during sequential infections suggest the presence of strain specific immunity. Am J Trop Med Hyg. 2002, 67: 8-16.","journal-title":"Am J Trop Med Hyg"},{"key":"391_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/IAI.66.1.239-246.1998","volume":"66","author":"D Eisen","year":"1998","unstructured":"Eisen D, Billman-Jacobe H, Marshall VF, Fryauff D, Coppel RL: Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect Immun. 1998, 66: 239-246.","journal-title":"Infect Immun"},{"key":"391_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0166-6851(94)90144-9","volume":"64","author":"PA Burghaus","year":"1994","unstructured":"Burghaus PA, Holder AA: Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol. 1994, 64: 165-169. 10.1016\/0166-6851(94)90144-9.","journal-title":"Mol Biochem Parasitol"},{"key":"391_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1128\/IAI.69.2.959-967.2001","volume":"69","author":"S Weisman","year":"2001","unstructured":"Weisman S, Wang L, Billman-Jacobe H, Nhan DH, Richie TL, Coppel RL: Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2. Infection and Immunity. 2001, 69: 959-967. 10.1128\/IAI.69.2.959-967.2001.","journal-title":"Infection and Immunity"},{"key":"391_CR16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/IAI.63.2.456-466.1995","volume":"63","author":"AF Egan","year":"1995","unstructured":"Egan AF, Chappel JA, Burghaus PA, Morris JS, McBride JS, Holder AA, Kaslow DC, Riley EM: Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun. 1995, 63: 456-466.","journal-title":"Infect Immun"},{"key":"391_CR17","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1128\/IAI.69.7.4390-4397.2001","volume":"69","author":"L Wang","year":"2001","unstructured":"Wang L, Richie TL, Stowers A, Nhan DH, Coppel RL: Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. Infect Immun. 2001, 69: 4390-4397. 10.1128\/IAI.69.7.4390-4397.2001.","journal-title":"Infect Immun"},{"key":"391_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1521-4141(200102)31:2<539::AID-IMMU539>3.0.CO;2-1","volume":"31","author":"H Jouin","year":"2001","unstructured":"Jouin H, Rogier C, Trape JF, Mercereau-Puijalon O: Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area. Eur J Immunol. 2001, 31: 539-550. 10.1002\/1521-4141(200102)31:2<539::AID-IMMU539>3.0.CO;2-1.","journal-title":"Eur J Immunol"},{"key":"391_CR19","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/IAI.63.11.4382-4388.1995","volume":"63","author":"RR Taylor","year":"1995","unstructured":"Taylor RR, Smith DB, Robinson VJ, McBride JS, Riley EM: Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun. 1995, 63: 4382-4388.","journal-title":"Infect Immun"},{"key":"391_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.4049\/jimmunol.173.1.666","volume":"173","author":"CC John","year":"2004","unstructured":"John CC, O'Donnell RA, Sumba PO, Moormann AM, de Koning-Ward TF, King CL, Kazura JW, Crabb BS: Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J Immunol. 2004, 173: 666-672.","journal-title":"J Immunol"},{"key":"391_CR21","doi-asserted-by":"publisher","first-page":"6185","DOI":"10.1128\/IAI.72.10.6185-6189.2004","volume":"72","author":"PH Corran","year":"2004","unstructured":"Corran PH, O'Donnell RA, Todd J, Uthaipibull C, Holder AA, Crabb BS, Riley EM: The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. Infect Immun. 2004, 72: 6185-6189. 10.1128\/IAI.72.10.6185-6189.2004.","journal-title":"Infect Immun"},{"key":"391_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/426398","volume":"191","author":"R Perraut","year":"2005","unstructured":"Perraut R, Marrama L, Diouf B, Sokhna C, Tall A, Nabeth P, Trape JF, Longacre S, Mercereau-Puijalon O: Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. J Infect Dis. 2005, 191: 264-271. 10.1086\/426398.","journal-title":"J Infect Dis"},{"key":"391_CR23","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1128\/IAI.72.11.6492-6502.2004","volume":"72","author":"DR Cavanagh","year":"2004","unstructured":"Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JA, Theander TG, Akanmori BD, Polley S, Conway DJ, Koram K, McBride JS: Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun. 2004, 72: 6492-6502. 10.1128\/IAI.72.11.6492-6502.2004.","journal-title":"Infect Immun"},{"key":"391_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.161.1.347","volume":"161","author":"DR Cavanagh","year":"1998","unstructured":"Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS: A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol. 1998, 161: 347-359.","journal-title":"J Immunol"},{"key":"391_CR25","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1128\/IAI.72.11.6300-6305.2004","volume":"72","author":"C Fluck","year":"2004","unstructured":"Fluck C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I: Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun. 2004, 72: 6300-6305. 10.1128\/IAI.72.11.6300-6305.2004.","journal-title":"Infect Immun"},{"key":"391_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.0141-9838.2004.00664.x","volume":"25","author":"I Felger","year":"2003","unstructured":"Felger I, Steiger S, Hatz C, Smith T, Beck HP: Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. Parasite Immunol. 2003, 25: 531-543. 10.1111\/j.0141-9838.2004.00664.x.","journal-title":"Parasite Immunol"},{"key":"391_CR27","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/IAI.71.6.3485-3495.2003","volume":"71","author":"S Franks","year":"2003","unstructured":"Franks S, Baton L, Tetteh K, Tongren E, Dewin D, Akanmori BD, Koram KA, Ranford-Cartwright L, Riley EM: Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect Immun. 2003, 71: 3485-3495. 10.1128\/IAI.71.6.3485-3495.2003.","journal-title":"Infect Immun"},{"key":"391_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-3024.2003.00636.x","volume":"25","author":"WG Metzger","year":"2003","unstructured":"Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ: Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol. 2003, 25: 307-312. 10.1046\/j.1365-3024.2003.00636.x.","journal-title":"Parasite Immunol"},{"key":"391_CR29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4269\/ajtmh.1998.58.406","volume":"58","author":"RR Taylor","year":"1998","unstructured":"Taylor RR, Allen SJ, Greenwood BM, Riley EM: IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg. 1998, 58: 406-413.","journal-title":"Am J Trop Med Hyg"},{"key":"391_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/322809","volume":"184","author":"T Staalsoe","year":"2001","unstructured":"Staalsoe T, Megnekou R, Fievet N, Ricke CH, Zornig HD, Leke R, Taylor DW, Deloron P, Hviid L: Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis. 2001, 184: 618-626. 10.1086\/322809.","journal-title":"J Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-6-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-6-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-6-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T20:48:18Z","timestamp":1683924498000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-6-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-6-86","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,2]]},"article-number":"86"}}